Onglyza Linked to Pancreatic Cancer
The popular diabetes type-2 treatment Onglyza (saxagliptin) was jointly developed by AstraZeneca and Bristol-Myers Squibb. Onglyza is a popular medication,
Read moreOpioid Increases risk of Neonatal Abstinence Syndrome
Opioid pain use during pregnancy increases risk Of NSA (Neonatal Abstinence Syndrome) Researchers at Vanderbilt University Medical Center studied neonatal
Read moreActos lawsuit settlement for $2.2 Billion
Takeda Pharmaceutical Co. has offered to pay more than $2.2 billion to resolve claims of hiding its Actos diabetes medicine’s
Read moreZofran linked to Deaths of Children
A recent study suggests that Zofran side effects may be fatal for some children. The study examines two children who were
Read moreZofran Lawsuit
Zofran Lawsuit Update Several medical studies have highlighted the risk of Zofran side effects, including cleft palate, cleft lip and
Read moreZofran NDC numbers in Lawsuit
The following table lists the NDCs and labelers of ZOFRAN: NDC Trade Name Labeler Name 55154-1132 ZOFRAN CARDINAL HEALTH PHARMACEUTICAL
Read moreZofran Birth Defect Warning
Attention Women. Zofran has been linked to serious birth defects. FDA Warns Against Zofran Use in Pregnancy The FDA has
Read moreBirth control pills linked to breast cancer
Study links certain birth control pills to higher Breast Cancer Risk among Women 20 to 49 Years of Age This
Read moreGlaxoSmithKline settles for $105 million
GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45
Read morePradaxa Lawsuits Settles For $650 Million
Boehringer Ingelheim Settles US Pradaxa Litigation For $650 Million Boehringer Ingelheim will pay $650 million in a “comprehensive settlement” of
Read more